Virtual Medicinal Product (VMP) - Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials Start Date 10-05-2022 End Date
Previous Name Previous Name Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials Start Date 13-01-2022 End Date 09-05-2022

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
0.5
UDFS UOM
ml
Unit Dose UOM
dose

Summary

Prescribing Status
Never Valid To Prescribe As A VMP
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Suspension for injection
Ontology Form/Route
suspensioninjection.intramuscular
Non-availability Indicator
Actual Products not Available
Name Basis
Other

Codes

ATC Code
n/a
BNF Start Date End Date
Current BNF 14040000 Start Date 04-04-2022 End Date
Previous BNF 14040000 Start Date 22-10-2020 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
39116211000001106 22-10-2020

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
8 dose
10 dose
80 dose
100 dose